Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: The first section of the review describes the recent therapies that have been used in humans, all of whom have been adults. The second section evaluates the use of agents given in experimental animal models during or after the onset of acute renal failure. The third section describes the many animal studies using therapies before the onset of experimental renal failure. The final section discusses how the emerging field of stem cell research might be used to treat acute renal failure. SUMMARY:
|
Authors | Carlton M Bates, Fangming Lin |
Journal | Current opinion in pediatrics
(Curr Opin Pediatr)
Vol. 17
Issue 2
Pg. 215-20
(Apr 2005)
ISSN: 1040-8703 [Print] United States |
PMID | 15800415
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S., Review)
|
Chemical References |
- PPAR alpha
- Pyrimidines
- Hepatocyte Growth Factor
- Atrial Natriuretic Factor
- pirinixic acid
- Nitric Oxide Synthase
- Heme Oxygenase-1
- Acetylcysteine
|
Topics |
- Acetylcysteine
(therapeutic use)
- Acute Kidney Injury
(metabolism, therapy)
- Animals
- Atrial Natriuretic Factor
- Disease Models, Animal
- Heme Oxygenase-1
(metabolism)
- Hepatocyte Growth Factor
(therapeutic use)
- Humans
- Nitric Oxide Synthase
(metabolism)
- PPAR alpha
(agonists, metabolism)
- Pyrimidines
(therapeutic use)
- Stem Cell Transplantation
(methods)
|